Stock GRIFOLS SA
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Grifols SA BME

Equities

ES0171996012

End-of-day quote BME
Other stock markets
- EUR - Intraday chart for Grifols SA
Apr. 15 Grifols Plans to Appoint Independent Directors Only to Audit, Compensation Committees MT
Apr. 15 Grifols to Add Independent Directors in Audit, Compensation Committees to Improve Governance MT

Chart calendar Grifols SA

d34a3f92fae000c09219acd60a6adf.nUltu3oX7o5NaGehYLaXgX-C23xspjkCQJbJwFXNFuk.7T0e7ztRl8AHBjHoGcz84BDBmCM_i11kD6-Zpx2IUa-reFjKCiehz3oGEA~3b0a92e374c438f4a69286bb69a0fe58

Upcoming events on Grifols SA

2024-05-13 Q1 2024 Earnings Release Pre-market
2024-07-24 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-02-26 Q4 2024 Earnings Release (Projected)
2025-05-12 Q1 2025 Earnings Release (Projected)

Past events on Grifols SA

2024-02-29 08:30 am Q4 2023 Earnings Call
2024-02-28 Q4 2023 Earnings Release Pre-market
2024-01-11 08:30 am Business Update Call
2023-11-02 08:30 am Q3 2023 Earnings Call
2023-11-02 03:56 am Q3 2023 Earnings Release
2023-07-27 08:30 am Q2 2023 Earnings Call
2023-07-27 02:53 am Q2 2023 Earnings Release
2023-06-16 06:00 am Annual General Meeting - Second Call
2023-06-15 06:00 am Annual General Meeting - First Call
2023-05-09 08:30 am Q1 2023 Earnings Call
2023-05-08 Q1 2023 Earnings Release Pre-market
2023-02-28 08:30 am Q4 2022 Earnings Call
2023-02-27 Q4 2022 Earnings Release Pre-market
2022-11-08 08:30 am Q3 2022 Earnings Call
2022-11-07 Q3 2022 Earnings Release Pre-market
2022-07-28 12:00 am Interim 2022 Earnings Call
2022-07-27 Interim 2022 Earnings Release Pre-market
2022-06-30 05:00 am Investor & Analyst Meeting
2022-06-10 06:00 am Annual General Meeting - Second Call
2022-06-09 06:00 am Annual General Meeting - First Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR		Released
Forecast
Spread 		5 099
5 077
0.42%		5 340
5 393
-0.99%		4 933
5 177
-4.71%		6 064
5 918
2.47%		6 592
6 613
-0.32%
7 093

EBITDA
Million EUR		Released
Forecast
Spread 		1 407
1 418
-0.79%		1 479
1 422
3.97%		962
1 214
-20.79%		1 221
1 231
-0.82%		1 455
1 404
3.62%
1 845

EBIT
Million EUR		Released
Forecast
Spread 		1 131
1 129
0.2%		996
1 094
-8.98%		595
868
-31.47%		806
837
-3.79%		1 023
901
13.55%
1 346

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		817
795
2.78%		879
895
-1.82%		350
651
-46.14%		361
466
-22.5%		224
360
-37.71%
773

Net income
Million EUR		Released
Forecast
Spread 		625
615
1.65%		619
636
-2.74%		183
434
-57.86%		208
265
-21.32%		59,3
142
-58.36%
489

EPS
EUR		Released
Forecast
Spread 		0,91
0,90
1.17%		0,90
0,93
-3.07%		0,27
0,61
-55.91%		0,31
0,39
-19.94%		0,09
0,22
-59.11%
0,79

Announcement Date27/02/2026/02/2128/02/2228/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2021 S1 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million EUR		Released
Forecast
Spread 		2 677
2 656
0.79%		2 537
2 492
1.81%		1 198
1 358
-11.78%		2 396
2 481
-3.42%		1 405
1 368
2.75%		1 543
1 568
-1.59%		2 810
2 717
3.42%		1 541
1 575
-2.16%		1 713
1 595
7.37%		3 254
3 094
5.17%		1 561
1 534
1.76%		1 663
1 650
0.81%		3 225
3 211
0.43%		1 597
1 609
-0.72%		1 770
1 756
0.8%
1 669


1 765


1 747


1 840

EBITDA
Million EUR		Released
Forecast
Spread 		731
638
14.7%		635
612
3.61%


327
524
-37.57%		248





618
557
10.96%		308
314
-1.94%		294
341
-13.77%		603


299
190
56.91%		361
345
4.69%		659
678
-2.66%		374
368
1.51%		426
433
-1.51%
401


459


456




EBIT
Million EUR		Released
Forecast
Spread 		422
396
6.39%		464
459
1.04%


132
276
-52.3%





427
424
0.69%		173
209
-17.08%		177
224
-21.17%		378
466
-18.81%		176
86,0
104.43%		254
236
7.67%


264
245
7.78%		329
307
7.21%
281


339


336




Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread


378
374
1.11%


-27,8
48,7
-157.08%





228
250
-8.91%		66,7
109
-38.87%		46,9
113
-58.33%		133
232
-42.51%		-84,2
-72,5
-16.1%		103
76,9
34.22%		19,0
-9,10
309.3%		99,6
107
-7.19%		105
149
-29.34%
49,8


69,8


81,8


107

Net income
Million EUR		Released
Forecast
Spread 		218
209
4.52%		267
254
5.07%


-84,0
5,28
-1692.64%





144
163
-12.01%		45,0
70,1
-35.81%		20,1
48,7
-58.76%		64,6
138
-53.05%		-108
-73,0
-48.31%		52,0
35,5
46.6%		-56,2
-77,0
26.99%		59,5
69,5
-14.35%		56,0
100
-44.15%
43,0


71,2


77,4


68,8

EPS
EUR		Released
Forecast
Spread


0,39
0,39
0%
0,28

-0,12
0,02
-614.36%





0,21
0,34
-38.24%



0,14

0,10
0,20
-50%
0,04

0,08
0,06
33.33%



0,08


0,12


0,11


0,18


0,17


0,05

Announcement Date30/07/2029/07/2128/02/2228/02/2228/07/2228/07/2228/07/2208/11/2228/02/2328/02/2309/05/2327/07/2327/07/2302/11/2328/02/24----

Upcoming sector events for Grifols SA

2024-04-19 HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-22 CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
2024-04-22 XIAMEN AMOYTOP BIOTECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-22 SAMSUNG BIOLOGICS CO.,LTD.: Q1 2024 Earnings Release (Projected)
2024-04-22 LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD.: Q4 2023 Earnings Release
2024-04-22 SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.: Q4 2023 Earnings Release
2024-04-22 CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.: Q4 2023 Earnings Release
2024-04-23 SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD: Q1 2024 Earnings Release (Projected)
2024-04-23 BIOMARIN PHARMACEUTICAL INC.: Q1 2024 Earnings Release
2024-04-23 BIOGEN INC.: Q1 2024 Earnings Release
More events

Past sector events for Grifols SA

2024-04-15 JIANGSU AIDEA PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-11 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.: Q4 2023 Earnings Release
2024-03-29 CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD.: Q4 2023 Earnings Release
2024-03-29 HUALAN BIOLOGICAL VACCINE INC.: Q4 2023 Earnings Release
2024-03-29 HUALAN BIOLOGICAL ENGINEERING INC.: Q4 2023 Earnings Release
2024-03-29 WALVAX BIOTECHNOLOGY CO., LTD.: Q4 2023 Earnings Release
2024-03-29 09:00 am SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release
2024-03-28 BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.: Q4 2023 Earnings Release
2024-03-28 TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-03-28 BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.: Q4 2023 Earnings Release
  1. Stock Market
  2. Equities
  3. GRF Stock
  4. Stock
  5. Calendar Grifols SA